SHINE allowed more flexibility in procuring production components

May 18, 2021, 9:29AMNuclear News
SHINE executives, construction managers, and partners commemorate a construction milestone of the medical isotope production facility in March. (Photo: SHINE)

The Nuclear Regulatory Commission has approved a request by SHINE Medical Technologies for an exemption from regulations on how commercial grade equipment is defined, allowing the company to more easily procure components for the medical isotope production facility it is building in Janesville, Wis.

To continue reading, log in or create a free account!

Related Articles

NRC approves NuScale uprated SMR design

June 2, 2025, 9:30AMNuclear News

NuScale earned approval for its “larger” US460 77-MWe small modular reactor plant design, the Nuclear Regulatory Commission announced last week.The standard design approval (SDA) is a...

NRC news roundup

Summer progress; Waterford news; safety report of Northeast plants

May 16, 2025, 9:30AMNuclear News

Here’s a look at some recent announcements from the Nuclear Regulatory Commission.Summer SLR: The NRC this month published its final environmental impact statement for Summer Unit 1’s...